Functional and Morphologic Findings at Four Years After Intravitreal Bevacizumab or Laser for Type 1 ROP. [electronic resource]
Producer: 20210414Description: 180-186 p. digitalISSN:- 2325-8179
- Angiogenesis Inhibitors -- administration & dosage
- Bevacizumab -- administration & dosage
- Female
- Follow-Up Studies
- Gestational Age
- Humans
- Infant, Newborn
- Intravitreal Injections
- Laser Coagulation -- methods
- Male
- Receptors, Vascular Endothelial Growth Factor -- antagonists & inhibitors
- Retina -- pathology
- Retinopathy of Prematurity -- diagnosis
- Retrospective Studies
- Time Factors
- Tomography, Optical Coherence -- methods
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.